All Articles

With the approval of its advanced cancer drug Eratrectinib, Vcare PharmaTech challenges global rivals, showcasing China's AI-driven R&D and strategic ambition.

Two new roadside signs honor Laura and Jamie Hannah, killed by an impaired driver. Their story is a tragic reminder of a preventable crisis on our roads.

New research reveals AI is no longer just assisting IT—it's taking control. A deep dive into the shift to autonomous operations and what it means for leaders.

Guelph's new bus chargers are more than infrastructure; they represent a new era of predictable federal funding reshaping municipal finance and strategy.

With a fresh $34.5M in capital, Volatus is set to expand manufacturing and advance its defense-grade drone tech. What does this signal for the industry?

A new pact with Galaxy Digital lets Morgan Stanley's elite clients swap crypto for ETPs. Is this the moment Wall Street fully embraces DeFi, or a risky new frontier?

Blink Charging is selling its Envoy subsidiary to focus on core infrastructure. This isn't just a deal; it's a sign that the EV industry's era of frantic growth is giving way to a new mandate: profitability.

Aiper's new partnership with charity: water isn't just philanthropy. It's a calculated move to link its backyard tech to the global water crisis, turning eco-conscious consumers into brand evangelists.

Market research shows doctors are eager to prescribe Moleculin's new AML drug, Annamycin. It offers hope where there is none, but can the company survive to deliver it?

As Florida celebrates National Homeownership Month, the dream of owning a home clashes with a perfect storm of insurance crises and affordability challenges.

A new firm offers up to $250k in funded accounts for prediction market traders, a move that could professionalize a booming sector. But can it navigate the complex regulatory field?

A new lawsuit alleges a Dallas nightclub's negligent security policy allowed a patron to bypass checks for a fee, leading to a security guard's murder.

Duke Energy's $500K in grants aids first responders, but it also reveals a growing reliance on private funds as public disaster support systems face strain.

With 460,000 providers enrolled, Careviso is tackling healthcare's most hated process. A case study shows it's cutting case times by more than half.

ALLSWIFIT's new Stedi Collection challenges the 'soft is best' mantra, betting that true all-day comfort comes from biomechanical support, not just cushioning.

How a Shark Tank alum is leveraging authentic heritage and a savvy distribution deal to redefine the multi-billion dollar American condiment market.

The federal government rolls out a dual strategy: immediate cash for households via a new grocery benefit and long-term investment to fuel Alberta's economy.

VFF's balance sheet didn't need the cash, so why take it? A deep dive into a strategic capital raise that's less about liquidity and more about legitimacy.

BioCardia’s innovative cell therapy for heart failure receives a crucial FDA signal, potentially paving the way for a new treatment paradigm for millions.

As titans clash for the World Cup betting market, The Sports Geek unveils a new playbook focusing on data, niche audiences, and the staggering cost of fandom.